Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.

Basit Öğe Kaydı
dc.contributor.authorTural, Deniz
dc.contributor.authorArslan, Cagatay
dc.contributor.authorSelcukbiricik, Fatih
dc.contributor.authorOlmez, Omer Fatih
dc.contributor.authorAkar, Emre
dc.contributor.authorErman, Mustafa
dc.contributor.authorUrun, Yuksel
dc.date.accessioned2024-05-19T14:51:34Z
dc.date.available2024-05-19T14:51:34Z
dc.date.issued2023
dc.departmentİstinye Üniversitesien_US
dc.descriptionGenitourinary Cancers Symposium -- FEB 16-18, 2023 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.urihttps://hdl.handle.net/20.500.12713/5972
dc.identifier.volume41en_US
dc.identifier.wosWOS:001098050200510en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subject[No Keywords]en_US
dc.titleComparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu